LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K192275
    Device Name
    invisa-RED ELITE
    Manufacturer
    IR Technology LLC
    Date Cleared
    2020-08-19

    (363 days)

    Product Code
    OLI
    Regulation Number
    878.5400
    Type
    Traditional
    Panel
    General & Plastic Surgery
    Reference & Predicate Devices
    K130341,K123237,K143741,K160880
    Why did this record match?
    Device Name :

    invisa-RED ELITE

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The InvisaRED™ Technology ELITE is indicated for use as a non-invasive dermatological aesthetic treatment for the temporary reduction of the circumference of waist, hips, and thighs through the process of photobiomodulation, affecting adipocyte cells within the adipose layer for the release of lipids from these cells.

    Device Description

    Device console:

    • Electrical Power: 110v
    • Cooling: Air Cooled
    • Operation: LCD touch screen
    • Allows Control of Individual Patient Session Protocol (Time, Energy, Pulse, Delay)
    • Integrated Device Power-On Self Test
    • Emergency Safety cut off switch
    • Treatment applicators (multi diode paddles) connected to the device console can number 8,10, or 12
    • Paddle Cooling: Air cooled
    • . Dual Coherent Frequencies: Thirteen (13) 680nm and thirteen (13) 980nm laser diodes on each paddle
    • Concurrent Laser Diode Mode of Operation: pulsed or continuous output
    • . Power output: Variable up to 200mw per diode for both 680nm and 980mm wavelengths
    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study that proves the device meets them, based on the provided text:

    Acceptance Criteria and Device Performance

    The core acceptance criterion for the InvisaRED™ Technology ELITE, as inferred from the clinical study, is the demonstration of superiority over a sham device in temporarily reducing the circumference of the waist, hips, and thighs.

    Acceptance Criteria (Primary Endpoint)Reported Device Performance (Invisa-RED Elite)
    Superiority to sham/placebo device in reducing measured body circumference (waist, hips, thighs)An estimated mean difference of 6.880 inches greater loss when comparing the totals of the measured areas of subjects treated with the Invisa-RED Elite vs. the placebo device.
    95% confidence interval: 3.715 inches to 10.046 inches
    Two-tailed P value:
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1